Drug Shortage Report for 5% DEXTROSE INJECTION, USP
Report ID | 34771 |
Drug Identification Number | 00060348 |
Brand name | DEXTROSE 5% INJ 5GM/100ML USP |
Common or Proper name | 5% Dextrose Injection, USP |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE |
Strength(s) | 5G |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS |
Packaging size | 100mL |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-08-15 |
Actual start date | 2017-08-15 |
Estimated end date | 2018-02-28 |
Actual end date | 2018-02-28 |
Shortage status | Resolved |
Updated date | 2018-03-01 |
Company comments | For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368. Customers can use the following alternate code upon their clinical judgement: JB0062P - Dextrose 5% 250 ml |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-03-01 | English | Compare |
v4 | 2018-02-28 | French | Compare |
v3 | 2018-02-28 | English | Compare |
v2 | 2018-01-03 | French | Compare |
v1 | 2018-01-03 | English | Compare |
Showing 1 to 5 of 5